Washington, United States,
08048034981
Menacan K3 Injection  Exporter to Washington, USA | City Drug Exporters INDIA
Leading Menacan K3 Injection Supplier from INDIA to Washington, USA | City Drug Exporters

City Drug Exporters supplies Menacan K3 Injection from INDIA to Washington, USA. Trusted pharmaceutical exporter for wholesalers, distributors, pharmacies, and healthcare procurement companies

Menacan K3 is a synthetic, fat-soluble Vitamin K analogue (Menadione Sodium Bisulfite). It functions as a precursor to active Vitamin K2 in the liver. It is used to treat and prevent bleeding disorders by facilitating normal blood coagulation and synthesizing clotting factors.

Mechanism of Action :

Carboxylation: Activates blood-clotting proteins by driving the gamma-carboxylation of glutamic acid residues.

Factor Synthesis: Promotes hepatic synthesis of critical coagulation factors: Factor II (prothrombin), Factor VII, Factor IX, and Factor X.

Conversion: The synthetic menadione molecule is converted directly into menaquinone (active Vitamin K2) upon entering the body.

Pharmacokinetics :

Metabolism: Rapidly metabolized in the liver into active forms.

Excretion: Primarily excreted via the biliary and renal pathways.

Onset: Acts quickly in clinical emergencies due to its direct action on liver enzymes.

Administration and Side Effects :

Routes: Administered via Intramuscular (IM), Intravenous (IV), or Subcutaneous (SC) injection.

Reactions: May cause mild local pain at the injection site, dizziness, or flushing.

Toxicity: High doses in infants can cause brain damage (kernicterus) or hemolytic anemia.

City Drug House Exporters provides:

Bulk supply for hospitals & distributors
Export to USA. Washington, INDIA
Regulatory documents (COA, MSDS, etc.)
Competitive pricing & reliable logistics

Contact for More Information :
📞 Contact City drug House Exporters from India

🌐 Websites:
https://www.citydrugexporters.com

📧 Email: citydrug123@gmail.com

📦 Business Type: Exporter | Bulk Supplier | Distributor

📲 WhatsApp: +91 9975390171
Jun 11th, 2026 3:00 PM

Keywords